Combinations of pyrimethanil and monoterpenes

US9320275B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9320275-B2
Application numberUS-201514753322-A
CountryUS
Kind codeB2
Filing dateJun 29, 2015
Priority dateJun 10, 2010
Publication dateApr 26, 2016
Grant dateApr 26, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to combinations of pyrimethanil, or a salt thereof, and a monoterpene, or a salt thereof, which provide an improved biocidal effect. More particularly, the present invention relates to compositions comprising a combination of pyrimethanil, or a salt thereof, together with a monoterpene selected from thymol and β-thujaplicin in respective proportions to provide a synergistic biocidal effect. Compositions comprising these combinations are useful for the protection of any living or non-living material, such as crops, plants, fruits, seeds, objects made of wood, thatch or the like, engineering material, biodegradable material and textiles against deterioration due to the action of microorganisms such as bacteria, fungi, yeasts, algae, viruses, and the like.

First claim

Opening claim text (preview).

The invention claimed is: 1. A composition comprising a combination of pyrimethanil as a component (I) and thymol as a component (II); whereby component (I) and component (II) are in respective proportions to provide a synergistic biocidal effect. 2. The composition as claimed in claim 1 wherein the ratio by weight of component (I) to component (II) ranges from 10:1 to 1:10. 3. The composition as claimed in claim 2 wherein the ratio by weight of component (I) to component (II) ranges from 4:1 to 1:4. 4. The composition according claim 1 wherein the amount of component (I) is present in a range from 10 to 50.000 mg/I and the amount of component (II) is present in a range from 10 to 50.000 mg/I. 5. A product containing (a) a composition comprising pyrimethanil as a component (I); and (b) a composition comprising as a component (II) a monoterpene compound is thymol, as a combination for simultaneous or sequential use, wherein said compositions (a) and (b) are in respective proportions to provide a synergistic biocidal effect.

Assignees

Inventors

Classifications

  • A01N43/54Primary

    1,3-Diazines; Hydrogenated 1,3-diazines · CPC title

  • Aromatic compounds {(B27K3/343 takes precedence)} · CPC title

  • containing keto or thioketo groups as part of a ring, e.g. cyclohexanone, quinone; Derivatives thereof, e.g. ketals · CPC title

  • Mixtures of different organic impregnating agents · CPC title

  • Oxygen or sulfur directly attached to an aromatic ring system · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9320275B2 cover?
The present invention relates to combinations of pyrimethanil, or a salt thereof, and a monoterpene, or a salt thereof, which provide an improved biocidal effect. More particularly, the present invention relates to compositions comprising a combination of pyrimethanil, or a salt thereof, together with a monoterpene selected from thymol and β-thujaplicin in respective proportions to provide a sy…
Who is the assignee on this patent?
Janssen Pharmaceutica Nv
What technology area does this patent fall under?
Primary CPC classification A01N43/54. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).